27 Jun, EOD - Indian

Nifty Pharma 21928.6 (0.55)

Nifty Smallcap 100 18976.8 (0.91)

Nifty IT 38822.95 (-0.44)

Nifty Next 50 68712.4 (0.61)

SENSEX 84058.9 (0.36)

Nifty Bank 57443.9 (0.41)

Nifty 50 25637.8 (0.35)

Nifty Midcap 100 59385.15 (0.27)

27 Jun, EOD - Global

NIKKEI 225 40150.79 (1.43)

HANG SENG 24284.15 (-0.17)

S&P 6232.75 (0.41)

LOGIN HERE

companylogoRaaj Medisafe India Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 524502 | NSE Symbol : | ISIN : INE548H01015 | Industry : Packaging |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
20-May-2025 29-May-2025 Accounts Raaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve Please be informed tat next meeting of the Board of Directors of the Company is scheduled to be held on Tuesday the 27th day of May 2025 inter-alia to take on record Audited Financial Statements for the year ended March 31 2025 and audited Financial Results for the quarter and year ended on March 31 2025. Other items to be transacted as given in the letter attached. Raaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve Please note that due to some unavoidable circumstances, the Board Meeting Earlier scheduled to be held on May 27, 2025 will now be held on Thursday, May 29, 2025 at 3.00 P.M. Agenda for the meeting shall remain the same as earlier informed vide our letter dated May 20, 2025 (As per BSE Announcement Dated on 23/05/2025) The Board of Directors has inter-alia approved/noted: the following : a. Financial Statements for the year ended on March 31, 2025 b. Audited Financial Results for the quarter/year ended March 31, 2025 and other statements Other items of business transacted at the meeting as per details in the letter attached (As Per BSE Announcement Dated on: 29/05/2025)
24-Mar-2025 29-Mar-2025 Others Raaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2025 inter alia to consider and approve Next Board Meeting is scheduled to be held on March 29 2025 at 3.00 PM at 75/2 & 3 Industrial Area Maksi Road Ujjain-456010 inter-alia to consider and approve sale of Building and shed situated at Plot No. 75/4 Industrial Area Maksi Road Ujjain-456010. Out-come of Board Meeting held on 29-03-2025, pursuant to Regulation 30 of SEBI (LODR) Regulations-2015 as per details attached herewith (As Per BSE Announcement Dated on: 29/03/2025)
03-Feb-2025 11-Feb-2025 Quarterly Results RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve We would like to inform you that next meeting of the Board of Directors is scheduled to be held on Tuesday the 11th day of February 2025 at 3.00 PM at the Registered Office at 75/2 & 3 Industrial Area Maksi Road Ujjain-456010 inter-alia to consider and to take on record Unaudited Financial Results of the Company for the Quarter ended December 31 2024 and other items of business as per letter attached herewith. The Board of Directors in its meeting held on today i.e. 11/02/2025, inter-alia, has approved and taken on record the Unaudited Financial Results for the quarter ended December 31, 2024 and also approved/taken on record other items of Business as per letter attached. We attach herewith unaudited financial results of the for the quarter ended December 31, 2024 which were reviewed to Audit Committee and taken on record by the Board of Directors of the Company in its meeting held on 11/02/025. (As Per BSE Announcement Dated on 11/02/2025)
05-Nov-2024 12-Nov-2024 Quarterly Results RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Board Meeting is convened on 12.11.2024 inter-alia to take on record Unaudited Financial Results of the Company for the quarter ended September 30 2024 and other reports/statements and other items as per Agenda attached. The Board of Directors has approved and taken on records the Unaudited Financial Results for the quarter ended September 30, 2024 and other statements related thereto. The Board of Directors has also approved/taken on record the other items as per letter attached (As Per BSE Announcement dated on 12.11.2024)
10-Aug-2024 14-Aug-2024 Quarterly Results RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve a. Appointment of Additional Directors (Non-executive Independent Directors) b. Re-designate Shri Arpit Bangur as Managing Director and Shri Navin Jhawar as Jt. Managing Director. c. Unaudited Financial Results for the quarter ended June 30 2024. Other Items as per agenda attached herewith. The Board of Directors in its meeting held on 14.08.2024 has approved the following changes in Board of Directors: a. Appointment of Managing Director b. Change in Designation c. Appointment of two additional directors (to be designated as Non-executive Independent Directors) (As Per BSE Announcement dated on 14.08.2024)
22-May-2024 29-May-2024 Accounts RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Next meeting of the Board of Directors is scheduled to be held on Wednesday 29th May 2024 at 3.00 PM at the Registered office of the Company inter-alia to consider and approve Financial Statements and cash flow statement for the year ended March 31 2024 and Financial Results of the Company for the quarter and year ended March 31 2024 and Statement of Assets and Liabilities as at March 31 2024 and other items of business as per agenda attached. The Board of Directors has inter-alia approved the Audited Financial Results and Cashflow Statement of the Company for the quarter/year ended March 31, 2024 and Statement of Assets and Liabilities as at March 31, 2024. Other items of Agenda have been approved/noted as per detailed letter attached. Read less.. (As Per BSE Announcement Dated on 29.05.2024)
03-May-2024 06-May-2024 Preferential Issue RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 inter alia to consider and approve Board Meeting is scheduled to be held on Monday May 06 2024 at 11.00 AM for Allotment of Equity Shares inter alia to consider and to approve allotment of 227500 Fully paid up equity Shares of Rs. 10 Each at a premium of Rs.34 per share Boar of Directors in its meeting held on today i.e. May 6, 2024 has approved the allotment of 2275000 Equity Shares of Rs. 10 each at a premium of Rs.34.00 Per share on Preferential Basis as per details given in the letter attached herewith. (As Per BSE Announcement Dated on 06/05/2024)
23-Feb-2024 29-Feb-2024 Increase in Authorised Capital RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/02/2024 inter alia to consider and approve Meeting of the Board of Directors is scheduled to be held on Thurday February 29 2024 inti-alia to consider increase in Authorised Capital and Preferential issue of equity shares. The Detailed Agenda is as per Letter attached herewith The Board of Directors inter-alia has approved: 1) Further issue of equity shares on Preferential Basis aggregating to Rs.1001.00 Lakhs; 2) Increase of Authorised Capital from Rs.1225.00 Lakhs to Rs.1500 Lakhs; 3) Convening of EGM and 4) Notice of EGM. Also Approved Additional Item of acquisition of Building, Plant and Machinery including lease hold rights of Plot No. 46, Industrial Growth Centre Sector III, Pithampur, District Dhar (MP) though a Bidding Process initiated by Bank of Baroda to recover its outstanding dues from Super Hygiene Private Limited Details of the Items approved are as per letter attached. (As per BSE Announcement Dated on 29/02/2024)
31-Jan-2024 09-Feb-2024 Quarterly Results RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve NOTICE is hereby given that the meeting of the Board of Directors of Raaj Medisafe India Limited is scheduled to be held on Friday the 9th day of February 2024 at 3.00 P.M. at 75/2 & 3 Industrial Area Maxi Road Ujjain-456010 to transact the following business: 1. To take note of Minutes of previous Board and committees meetings. 2. To consider and to approve Unaudited Financial Results for the quarter ended December 31 2023 and to take note of the Limited Review Report for the quarter ended on that date. 3.To adopt Reconciliation of Share Capital Audit for the quarter ended December 31 2023. 4.To take on record the following reports for the quarter ended December 31 2023 submitted to BSE: a. the Statement of Investors complaints; b. Shareholding Pattern; c. Corporate Governance Report; and d. Certificate under Regulation 74(5) of the SEBI (DP) Reg. 2018. Any other item may be taken up for consideration with the consent of a majority of the Directors present in the Meeting. The Board of Directors of the company inter-alia approved and taken on record unaudited financial results for the quarter ended December 31, 2023. Other items transacted as per details in the letter attached (As per BSE Announcement Dated on 09/02/2024)
08-Jan-2024 16-Jan-2024 Expansion RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/01/2024 inter alia to consider and approve To consider and approve expansion of existing manufacturing capacities of the Company as per letter attached. The Board of Directors has inter alia approved the expansion plan of manufacturing capacities of the Company as per details given in the letter attached herewith. (As per BSE Announcement Dated on 16/01/2024)
30-Oct-2023 08-Nov-2023 Quarterly Results RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve To consider and to approve Unaudited Financial Results for the quarter ended September 30 2023 Cash Flow Statement and Statement of Assets and Liabilities as at September 30 2023. and other items as per Agenda Attached The Board of Directors in its meeting held on today i.e. November 8, 2023 at 3.00 PM and concluded at 4.00 PM has inter-alia, approved/taken on record Unaudited Financial Results for the quarter and Half year ended September 30, 2023. The Board has also approved/taken on record the other items in the aforesaid meeting as per letter attached herewith. Unaudited Financial Results for the Quarter and Half year ended Septmber 30, 2023, Statement of Assets and Liabilities as on that date, Cash flow statement for the period ended September 30, 2023 and Limited Review Report dated 08.11.2023 issued by Statutory Auditors is attached herewith. (As Per BSE Announcement Dated on 08/11/2023)
29-Jul-2023 08-Aug-2023 Quarterly Results RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 inter alia to consider and approve A meeting of the Board of Directors of M/s Raaj Medisafe India Limited is scheduled to be held on Tuesday the 8th day of August 2023 at 3.00 P.M. at 75/2 & 3 Industrial Area Maxi Road Ujjain-456010 to transact the following business: a. To take on record Unaudited Financial Results for the quarter ended June 30 2023. b. To approve the Directors Report for the year ended March 31 2023. c. To convene 38th AGM to approve Notice of said AGM and Fix the dates for Book Closure. Other Items of Business to be transacted are as per letter dated 29.07.2023 attached herewith. The Board of Directors in its meeting held on today i.e. August 8, 2023 at 3.00 PM and concluded at 3.30 PM has inter-alia, approved/taken on record the following: (1) Taken on Record Unaudited Financial Results for the quarter ended June 30, 2023. (2) Fixed the date for 38th AGM to be held on Wednesday, the 27th September, 2023 at 3.00 PM through VC/OAVM (3) Approved Directors' Report and Corporate Governance for the year ended March 31, 2023. (4) Fixed the dates for Closure of Register of Members and Share Transfer Books from 21.09.2023 to 27.09.2023. (5) Approved the Notice for convening 38th AGM to be held on Wednesday, the 27th September, 2023. The Board has also approved/taken on record the other items in the aforesaid meeting as per letter attached herewith. (As Per BSE Announcement dated on 08.08.2023)
20-May-2023 29-May-2023 Accounts RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve The meeting of the Board of Directors of M/s Raaj Medisafe India Limited is scheduled to be held on Monday the 29th day of May 2023 at 3.00 P.M. at its Registered office at 75/2 & 3 Industrial Area Maxi Road Ujjain-456010 inter-alia to take on record Audit Financial Results for the quarter/Year ended March 31 2023. Other business proposed to be transacted at the aforesaid meeting is as per letter attached Board of Directors of the Company has inter-alia approved and taken on record the Audited Financial Statements for the quarter/year ended March 31, 2023. The Board has also approved/noted the other items of business as per detailed letter attached. (As Per BSE Announcement dated on 29.05.2023)
31-Jan-2023 13-Feb-2023 Quarterly Results RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 inter alia to consider and approve 1. To take note of Minutes of previous Board meetings and committees. 2.To approve Unaudited Financial Results for the quarter ended 31st Dec.2022. 3. To take note of the Related Party Transactions entered during the quarter ended 31st Dec.2022. 4. To adopt Reconciliation of Share Capital Audit for the quarter ended 31st Dec.2022. 5. To take on record: (a).Statement of Investors complaints and Shareholding Pattern for the quarter ended 31st Dec.2022(b)Corporate Governance Report for the quarter ended 31st Dec.2022 (c). Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st Dec.2022. (d). Compliance Certificate pursuant to provisions of Regulation 3(5) and 3(6) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 for the Quarter ended 31st Dec.2022. Any other item may be taken up. The Board Meeting to be held on 08/02/2023 has been revised to 13/02/2023 The Board Meeting to be held on 08/02/2023 has been revised to 13/02/2023 (As Per BSE Announcement Dated 06/02/2023) The Board of Directors of the Company in its meeting held on 13-02-2023 has inter-alia approved and taken on record Unaudited Financial Results of the Company for the quarter ended December 31, 2022. The Board of Directors has also approved/taken on record other items transacted at the said meeting as per letter attached. Pursuant to clause 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 we enclose herewith- a. Unaudited Quarterly Financial Results of the Company for the quarter ended on December 31, 2022. b. Limited Review Report for the Quarter ended December 31, 2022 issued by Statutory Auditors of the company. The above Statements/reports have been reviewed by audit committee and taken on record by the Board of Directors of the Company in its meeting held on February 13, 2023. (As Per BSE Announcement Dated on 13/02/2023)
29-Oct-2022 11-Nov-2022 Quarterly Results RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 inter alia to consider and approve 1.To take note of Minutes of previous Board meetings and committees. 2.To approve shifting of Registered Office of the Company from Pithampur to Ujjain. 3 To avail the services of Receivable Exchange of India Limited (RXIL) for e-discounting/electronic factoring services on its electronic platform TReDS (TReDS) and to authorize persons for the same.4.To approve Transaction to be entered with Related Party. 5.To consider and to approve Unaudited Financial Results for the qtr. ended Sept. 30 2022 and Statement of Assets and Liabilities as at Sept. 30 2022. 6.To adopt Reconciliation of Share Capital Audit for the qtr. ended 30th Sept. 2022. 7.To take on record: a.the Statement of Investors complaints and Shareholding Pattern for the qtr. ended Sept. 30 2022 b.Corporate Governance Report for the qtr. ended Sept. 30 2022. c. Related party transactions for the half year ended Sept 30 2022. d. Cert. under Reg. 74(5) of the SEBI (DP) Reg. 2018 for the qtr. ended Sept. 30 2022 The Board of Directors in its meeting held on November 11, 2022 has inter-alia taken on record Unaudited Financial Results for quarter ended September 30, 2022, Statement of Assets and Liabilities as at September 30, 2022 and Cash Flow Statement. and also approved/noted the other items as mentioned in the letter of dated attached. Pursuant to clause 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 we enclose herewith- a. Unaudited Quarterly Financial Results of the Company for the quarter ended on September 30, 2022 together with Cash Flow Statement for the period ended on that date. b. Limited Review Report for the Quarter ended September 30, 2022 issued by Statutory Auditors of the company. c. Statement of Assets and Liabilities of the company as at September 30, 2022. The above Statements/reports have been reviewed by audit committee and taken on record by the Board of Directors of the Company in its meeting held on November 11, 2022. (As Per BSE Announcement dated on 11.11.2022) Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our letter dated November 11, 2022, Intimation of outcome of Board meeting', we would like to inform you as under: a. Pursuant to Special Resolution passed by the shareholders of the Company in their Annual General Meeting held on 28.09.2022, the Board of Directors of the Company in its meeting held on November 11, 2022 has decided to Shift the situation of Registered Office of the Company from Pithampur to Ujjain with effect from November 15, 2022. b. Accordingly the Registered Office of the Company has been shifted with effect from November 15, 2022 to the address given hereunder: Raaj Medisafe India Limited 75/2 and 3, Industrial Area, Maxi Road, Ujjain - 456010 Email ID: raajmedisafe@gmail.com Phone: 0734 2518989 2513349 (As Per BSE Announcement Dated on 16/11/2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +